News
January 30, 2008 - Iroko Pharmaceuticals (Iroko) acquired all non-U.S. commercial rights to Aggrastat (tirofiban HCl) from Merck & Co. Inc., used for patients undergoing coronary angioplasty or atherectomy to prevent cardiac ischemic complications, in a move Iroko hopes will strengthen its presence in the cardiovascular market.
January 29, 2008
News
January 30, 2008 - TopSpin Medical Inc. installed the Cathamaran Intravascular MRI System at ZOL Hospital in Belgium, marking the first installation of the system and its entrance in a study on vulnerable plaque.
January 29, 2008News
January 30, 2008 - Cardica Inc.’s C-Port Distal Anastomosis Systems will be used in two courses to train cardiothoracic ...
January 29, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
January 30, 2008 - TopSpin Medical Inc. announced the first commercial installation of the Cathamaran Intravascular MRI System at ZOL Hospital, Genk, Belgium, with the first procedures performed on Jan. 16.
January 29, 2008Technology
NEC Electronics America Inc. introduced two new color, 21.3-inch diagonal amorphous-silicon thin-film transistor (TFT) liquid-crystal display (LCD) modules for medical imaging applications.
January 28, 2008News
January 29, 2008 - The Medicines Company received the European Commission�s authorization of an expanded use for ...
January 28, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025Technology
Spectrum Surgical Instruments Corp. has assembled 42 brushes in designing its endoscopic instrument cleaning brush kit ...
January 28, 2008Feature | Dave Fornell
February 2008 - The body regulates its core temperature by reducing the blood flow to the extremities, but anesthesia ...
January 28, 2008News
January 29, 2008 � A novel treatment for blood clots in the legs, in which injecting or �lacing� the clot with a ...
January 28, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024Technology
Janssen-Cilag International NV announced IONSYS (fentanyl iontophoretic transdermal system), a new needle-free system ...
January 28, 2008News
January 29, 2008 - Edwards Lifesciences Corp. received conditional approval from the FDA for the addition of the ...
January 28, 2008News
January 28, 2008 - A new multi-center, international clinical trial that compares the safety and effectiveness of thoracic endovascular aortic repair (TEVAR) to open surgery for descending thoracic aortic aneurysms (TAA), indicates that TEVAR (the less invasive endovascular graft) is a promising treatment option for many patients.
January 28, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024Technology
Power Medical Interventions Inc. said the FDA cleared its 510(k) application for marketing its intelligent iDrive ...
January 28, 2008News
January 28, 2008 - Inverness Medical Innovations will acquire Matria Healthcare, Inc. for approximately $1.18 billion, consisting of approximately $900 million to acquire the Matria shares of common stock and assumption of approximately $280 million of Matria's indebtedness outstanding, which will further Inverness' approach of bringing its proprietary diagnostic products into the home.
January 27, 2008Technology
Terumo Interventional Systems offers the AZUR Peripheral HydroCoil Embolization System for the occlusion of blood vessels, vascular malformations and aneurysms, extending its interventional device portfolio.
January 27, 2008